Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome.
about
Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycleMetabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom controlEthinylestradiol30μg-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathyIs reducing ovarian volume in polycystic ovarian syndrome patients after administration of metformin associated with improving cardiovascular risk factors?The physiological basis of complementary and alternative medicines for polycystic ovary syndrome.Vitamin B12 deficiency in an adolescent girl with polycystic ovarian syndrome.Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.Microarray analysis of differential gene expression profile in peripheral blood cells of patients with human essential hypertension.Assessing and treating insulin resistance in women with polycystic ovarian syndromeAntioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials.Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.The effects of old, new and emerging medicines on metabolic aberrations in PCOS.Metformin and its clinical use: new insights for an old drug in clinical practice.Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary SyndromeCardiovascular Risk in Women With PCOS.A marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate.Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.Hypermethylation: Causes and Consequences in Skeletal Muscle Myopathy.The Effect of Metformin Treatment on the Serum Levels of Homocysteine, Folic Acid, and Vitamin B12 in Patients with Polycystic Ovary Syndrome.Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome.Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome.Vitamin B12 and homocysteine status during pregnancy in the metformin in gestational diabetes trial: responses to maternal metformin compared with insulin treatment.Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis.Synthesis, Characterization, and Biological Evaluations of 1,3,5-Triazine Derivatives of Metformin Cyclization with Berberine and Magnolol in the Presence of Sodium Methylate.The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome.Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
P2860
Q26745509-A806A8F8-209C-4E43-AE5A-A2A3B762818CQ26852079-D5D17517-787C-48E1-8884-170B9A56D883Q31065780-54D1C36E-EC80-4ABD-ABFB-9AC9C5B00F51Q33704116-EBA773D7-DE24-466F-B7D6-866D9DE80C79Q33764478-233C54D4-C20F-44ED-9985-5467ED116330Q34026512-EB05FD67-8062-49A6-8AC9-76B4C21BB9BCQ34160598-7F2D04A8-0602-4C1C-A097-224EC1183483Q34321879-5E9B5C87-1AEA-40BB-85C2-34371D4430B5Q34616510-D3F62513-BBB3-404C-A30F-97727ECAE484Q34878055-49E3A0D6-3DD2-4E58-BE9E-1F0F6385B1F5Q35015466-EBF5C278-63E0-4ED1-A979-8D25E9F2B7BEQ36209145-6B3A9FE3-68A5-4A09-A9D6-9C657BE400BEQ36328060-CAF784E7-B0BC-4B0F-B6F9-6816B6EC00C7Q36423076-AF1E9818-DE0D-41BA-B938-CB7BCD627EBCQ36758279-77AC31EC-B209-482E-886D-A2AB39D6ECB6Q36957415-2B1AEB4F-D23B-4539-B8C3-96ADBA2FC80AQ37170305-24EA4F24-387E-44BF-963C-782D46687982Q37990356-7A4B7EC4-E1CB-4E73-BF23-0027F82EEA3EQ39041123-2FA77DD2-C933-4B2F-B322-F29C1F32B882Q41626049-BBCAAC44-01A6-4585-AB72-EADC4E3340DEQ43871392-7C4DC8BD-20C2-421D-A14A-6D6072FA53F1Q44243871-C18E88F3-1CC6-4036-AFA3-3528E1D583CCQ45383159-B8BA4014-88D7-4F56-A4B3-B4237A45AE43Q49985475-71C273CD-BC6F-4834-8D19-E47614D45667Q50067030-C991927E-0234-4CEB-979C-AEC609104205Q50866777-B94DF521-83A3-4385-92FA-5E2D78A47BC2Q51322605-68A93F5B-B716-46C6-A352-51CB0B4EED30
P2860
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Effects of metformin with or w ...... ith polycystic ovary syndrome.
@ast
Effects of metformin with or w ...... ith polycystic ovary syndrome.
@en
type
label
Effects of metformin with or w ...... ith polycystic ovary syndrome.
@ast
Effects of metformin with or w ...... ith polycystic ovary syndrome.
@en
prefLabel
Effects of metformin with or w ...... ith polycystic ovary syndrome.
@ast
Effects of metformin with or w ...... ith polycystic ovary syndrome.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Effects of metformin with or w ...... ith polycystic ovary syndrome.
@en
P2093
Achille Tolino
Angela Falbo
Francesco Giallauria
Francesco Orio
Tiziana Russo
P2860
P304
P356
10.2337/DC09-1516
P407
P577
2009-11-23T00:00:00Z